Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 5
1983 4
1984 4
1985 19
1986 12
1987 14
1988 14
1989 21
1990 21
1991 22
1992 32
1993 26
1994 24
1995 33
1996 27
1997 30
1998 37
1999 31
2000 19
2001 27
2002 23
2003 31
2004 29
2005 21
2006 20
2007 25
2008 20
2009 16
2010 9
2011 22
2012 21
2013 19
2014 18
2015 19
2016 17
2017 18
2018 11
2019 14
2020 6
2021 12
2022 19
2023 13
2024 13
2025 19
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

821 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.
Keij FM, Kornelisse RF, Hartwig NG, van der Sluijs-Bens J, van Beek RHT, van Driel A, van Rooij LGM, van Dalen-Vink I, Driessen GJA, Kenter S, von Lindern JS, Eijkemans M, Stam-Stigter GM, Qi H, van den Berg MM, Baartmans MGA, van der Meer-Kappelle LH, Meijssen CB, Norbruis OF, Heidema J, van Rossem MC, den Butter PCP, Allegaert K, Reiss IKM, Tramper-Stranders GA. Keij FM, et al. Lancet Child Adolesc Health. 2022 Nov;6(11):799-809. doi: 10.1016/S2352-4642(22)00245-0. Epub 2022 Sep 9. Lancet Child Adolesc Health. 2022. PMID: 36088952 Clinical Trial.
A margin of 3% was deemed to indicate non-inferiority, thus if the reinfection rate in the oral amoxicillin-clavulanic acid group was less than 3% higher than that in the intravenous antibiotic group the null hypothesis would be rejected. ...In the intention-to-trea …
A margin of 3% was deemed to indicate non-inferiority, thus if the reinfection rate in the oral amoxicillin-clavulanic acid gr …
Short Oral Antibiotic Therapy for Pediatric Febrile Urinary Tract Infections: A Randomized Trial.
Montini G, Tessitore A, Console K, Ronfani L, Barbi E, Pennesi M; STOP Trial Group. Montini G, et al. Pediatrics. 2024 Jan 1;153(1):e2023062598. doi: 10.1542/peds.2023-062598. Pediatrics. 2024. PMID: 38146260 Free article. Clinical Trial.
Secondary end points were the difference in prevalence of clinical recovery, adverse drug-related events, and resistance to amoxicillin-clavulanic acid and/or to other antibiotics when a recurrent infection occurred. RESULTS: From May 2020 through September 2022, 17 …
Secondary end points were the difference in prevalence of clinical recovery, adverse drug-related events, and resistance to amoxicillin-c …
Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use.
Todd PA, Benfield P. Todd PA, et al. Drugs. 1990 Feb;39(2):264-307. doi: 10.2165/00003495-199039020-00008. Drugs. 1990. PMID: 2184003 Review.
Clavulanic acid enhances the antibacterial spectrum of amoxicillin by rendering most beta-lactamase-producing isolates susceptible to the drug. ...Thus, in general practice environments where beta-lactamase production has restricted the effectiveness of amoxicillin, …
Clavulanic acid enhances the antibacterial spectrum of amoxicillin by rendering most beta-lactamase-producing isolates suscept …
Does the use of amoxicillin/amoxicillin-clavulanic acid in third molar surgery reduce the risk of postoperative infection? A systematic review with meta-analysis.
Menon RK, Gopinath D, Li KY, Leung YY, Botelho MG. Menon RK, et al. Int J Oral Maxillofac Surg. 2019 Feb;48(2):263-273. doi: 10.1016/j.ijom.2018.08.002. Epub 2018 Aug 23. Int J Oral Maxillofac Surg. 2019. PMID: 30145064
However, with the exclusion of randomized controlled trials with a split-mouth design (due to an inadequate crossover period after antibiotic treatment), only amoxicillin-clavulanic acid was found to be effective (RR 0.21, P<0.001). The risk of adverse effects wa …
However, with the exclusion of randomized controlled trials with a split-mouth design (due to an inadequate crossover period after antibioti …
A meta-analysis of the use of amoxycillin-clavulanic acid in surgical prophylaxis.
Wilson AP, Shrimpton S, Jaderberg M. Wilson AP, et al. J Hosp Infect. 1992 Nov;22 Suppl A:9-21. doi: 10.1016/s0195-6701(05)80003-9. J Hosp Infect. 1992. PMID: 1362755
The efficacy of amoxycillin-clavulanic acid as antibiotic prophylaxis in surgery has been assessed in numerous clinical studies, chiefly in abdominal and gynaecological surgery. ...In addition, amoxycillin-clavulanic acid may have benefits in terms of …
The efficacy of amoxycillin-clavulanic acid as antibiotic prophylaxis in surgery has been assessed in numerous clinical studie …
Efficacy of amoxicillin and amoxicillin/clavulanic acid in the prevention of infection and dry socket after third molar extraction. A systematic review and meta-analysis.
Arteagoitia MI, Barbier L, Santamaría J, Santamaría G, Ramos E. Arteagoitia MI, et al. Med Oral Patol Oral Cir Bucal. 2016 Jul 1;21(4):e494-504. doi: 10.4317/medoral.21139. Med Oral Patol Oral Cir Bucal. 2016. PMID: 26946211 Free PMC article.
BACKGROUND: Prophylactic use of amoxicillin and amoxicillin/clavulanic acid, although controversial, is common in routine clinical practice in third molar surgery. ...With amoxicillin/clavulanic acid, the risk decreases significantly. Nevertheless, con …
BACKGROUND: Prophylactic use of amoxicillin and amoxicillin/clavulanic acid, although controversial, is common in routine clin …
Efficacy of amoxicillin or amoxicillin and clavulanic acid in reducing infection rates after third molar surgery: a systematic review and meta-analysis.
Wang R, Liu XG. Wang R, et al. Eur Rev Med Pharmacol Sci. 2022 Jun;26(11):4016-4027. doi: 10.26355/eurrev_202206_28972. Eur Rev Med Pharmacol Sci. 2022. PMID: 35731073 Free article.
OBJECTIVE: The current review was designed to assess the efficacy of amoxicillin (AMX) and amoxicillin-clavulanic acid (AMX-CLA) for reducing infection rates after third molar surgery. MATERIALS AND METHODS: PubMed, Embase, ScienceDirect, and Google Scholar were sea …
OBJECTIVE: The current review was designed to assess the efficacy of amoxicillin (AMX) and amoxicillin-clavulanic acid (AMX-CL …
821 results